Cierra N. Sharp

Cierra N. Sharp

Jun 14, 2016

Group 6 Copy 16
0
    Please wait...

    About This Project

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Household Composting Toilets for Agriculture in Malawi

    Ninety percent of Malawi does not have access to improved sanitation. 90% of the people also work in agriculture...

    How do lichens withstand desiccation?

    Lichens, symbioses between fungi and algae, survive levels of desiccation lethal to most organisms. We recently...

    Creating a neural network that classifies Dinoflagellate species

    I think we have the technology to develop an artificial intelligence model that can differentiate between Dinoflagellates...

    Backer Badge Funded